Mergers and acquisitions – Page 13

Business
US tax changes ripple into merger deals

2014-10-08T00:00:00Z

Efforts to curb tax-avoiding ‘inversion’ deals will slow, but not stop, the wave
Business
Actavis boosts antibiotics with Durata buyout

2014-10-08T00:00:00Z

$820 million deal gives Actavis control of newly-approved intravenous antibiotic
Business
Becton Dickinson to buy CareFusion for $12bn

2014-10-07T00:00:00Z

Medical devices merger continues consolidation trend
Business
J&J to buy antiviral specialist Alios

2014-10-01T00:00:00Z

$1.75 billion deal brings Phase II compounds for hepatitis C and respiratory syncytial virus
Business
Mitsubishi to buy Japanese gases specialist

2014-09-30T00:00:00Z

Taiyo Nippon Sanso acquisition continues consolidation in Japan’s chemical industry
Business
Lumara splits and sells to AMAG and Perrigo

2014-09-30T00:00:00Z

Lumara has just emerged from bankruptcy and brings a drug for suppressing pre-term birth, plus other women’s health products
Business
Merck KGaA to buy Sigma–Aldrich

2014-09-26T00:00:00Z

$17bn acquisition expands Merck’s life science business and US presence, but it isn’t stepping back from drug development
Business
Bayer to sever polymer arm

2014-09-23T00:00:00Z

German chemical giant’s exit from the materials world will help fund its crop and healthcare ambitions
Business
Eastman snaps up Taminco for $2.8bn

2014-09-12T00:00:00Z

Purchase will strengthen Eastman in niche markets and offers cost savings
Business
Roche to buy InterMune for respiratory boost

2014-08-29T00:00:00Z

$8.3bn deal gives Roche a leading position in pulmonary fibrosis
Business
Clinical collaborations drive cancer immunotherapy

2014-08-27T00:00:00Z

Companies race to pair up chemotherapy drugs with immune system-boosting antibodies to greatest effect in trials
Business
Illumina targets cancer diagnostics

2014-08-22T00:00:00Z

Sequencing will improve tests and speed up clinical trials processes for big pharma partners
Business
Sanofi snaps up inhaled insulin licence

2014-08-12T00:00:00Z

Deal gives Mannkind access to global manufacturing and distribution for recently-approved Afrezza
Business
AstraZeneca stocks respiratory and cancer pipelines

2014-07-31T00:00:00Z

A $2bn deal with Almirall and a raft of acquisitions and partnership deals bulk up two focus areas for the company
Business
Bruker winds down underperforming instrument lines

2014-07-30T00:00:00Z

Stand-alone gas chromatographs and certain mass spectrometry products to be sold off
Business
Reckitt Benckiser to spin out US pharma arm

2014-07-28T00:00:00Z

Declining heroin addiction treatment sales prompt divestment as company focuses on over-the-counter and consumer products
Business
Pharma firms rush to escape US tax shackles

2014-07-25T00:00:00Z

AbbVie–Shire and Mylan–Abbott mergers both allow US firms to escape to lower-tax European countries
Business
Albemarle buys into lithium with Rockwood merger

2014-07-23T00:00:00Z

$6.2 billion deal capitalises on battery market growth
Business
ADM to buy food ingredients specialist Wild Flavors

2014-07-08T00:00:00Z

€2.3bn deal gets ADM into rapidly-growing area of naturally-sourced flavourings
Business
Ineos takes full control of Styrolution

2014-07-03T00:00:00Z

€1.1bn deal sees BASF complete its planned exit from styrenics joint venture